Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

THE prehistoric “super carnivore” megalodon was bigger than previously thought, growing to a whopping 80ft and weighing 94 tons. The beast would have been four times bigger than the largest great ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Saudi Aramco leads with a market cap of $1.65 trillion, distinct from others in the trillion-dollar club. ExxonMobil and Chevron follow, marking significant U.S. presence in global energy leadership.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close. Explore the world of large-cap stocks and learn how these can shape your portfolio.

Although battleships were replaced by aircraft carriers by the end of World War II, they remain a testament to a bygone era of warfare—and a symbol of their nations’ might. For nearly half a century, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...